TickerFactsScreenerDevelopers

STANDARD BIOTOOLS INC. (LAB) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2008: $17.80M2009: $14.60M2010: $5.72M2011: $13.55M2012: $58.65M2013: $35.26M2014: $33.71M2015: $29.12M2016: $35.05M2017: $58.06M2018: $95.40M2019: $21.66M2020: $68.52M2021: $28.45M2022: $81.31M2023: $51.70M2024: $166.73M2025: $120.86M$120.86M
2008Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$120.86M-27.5%
2024$166.73M+222.5%
2023$51.70M-36.4%
2022$81.31M+185.8%
2021$28.45M-58.5%
2020$68.52M+216.3%
2019$21.66M-77.3%
2018$95.40M+64.3%
2017$58.06M+65.7%
2016$35.05M+20.4%
2015$29.12M-13.6%
2014$33.71M-4.4%
2013$35.26M-39.9%
2012$58.65M+332.7%
2011$13.55M+136.8%
2010$5.72M-60.8%
2009$14.60M-17.9%
2008$17.80M—